Steven D. Shnyder

Tumbling Hill
Bradford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Correction to "Controlled Bioactive Delivery Using Degradable Electroactive Polymers".

Correction to "Controlled Bioactive Delivery Using Degradable Electroactive Polymers".

Journal: Biomacromolecules

Published: September 15, 2025

Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents.

Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 01, 2025

A Novel Modulator of Resistance for Oxaliplatin-Based Therapy for Colorectal Cancer: The ESCRT Family Member VPS4A.

A Novel Modulator of Resistance for Oxaliplatin-Based Therapy for Colorectal Cancer: The ESCRT Family Member VPS4A.

Journal: Cells

Published: May 15, 2025

K562 Chronic Myeloid Leukemia Cells as a Dual β3-Expressing Functional Cell Line Model to Investigate the Effects of Combined αIIbβ3 and αvβ3 Antagonism.

K562 Chronic Myeloid Leukemia Cells as a Dual β3-Expressing Functional Cell Line Model to Investigate the Effects of Combined αIIbβ3 and αvβ3 Antagonism.

Journal: Methods and protocols

Published: March 17, 2025

Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.

Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.

Journal: RSC medicinal chemistry

Published: April 29, 2024

A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer.

A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer.

Journal: Cells

Published: December 20, 2023

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy.

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy.

Journal: Cancers

Published: June 15, 2023

Controlled Bioactive Delivery Using Degradable Electroactive Polymers.

Controlled Bioactive Delivery Using Degradable Electroactive Polymers.

Journal: Biomacromolecules

Published: June 24, 2022

Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation.

Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation.

Journal: Chembiochem : a European journal of chemical biology

Published: May 04, 2022

Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer.

Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer.

Journal: Frontiers in pharmacology

Published: February 14, 2022

Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Journal: Progress in the chemistry of organic natural products

Published: April 02, 2021

Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.

Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.

Journal: Scientific reports

Published: January 02, 2021

Showing 1-12 of 43

Last Updated: 09/26/2026